U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07054905) titled 'Prediction of Hyperkalemia in Dialysis Patients Through Waveform Analysis Using Wearable ECG' on June 27.
Brief Summary: This study aims to evaluate whether hyperkalemia, a potentially life-threatening condition in dialysis patients, can be detected early using a wearable single-lead ECG device. Patients with chronic kidney disease undergoing hemodialysis will wear a chest-attached ECG sensor (HiCardi) during dialysis sessions. ECG data will be collected four times over six weeks, in coordination with routine blood tests measuring serum potassium levels. The goal is to analyze changes in ECG waveforms, such as T waves, and determine ...